Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Community workers, activists and scholars to discuss Gender-based violence
2012-10-03

The Gender Studies Programme and Gender Initiative attached to the Dialogue between Science and Society Series at the University of the Free State is holding a one-day symposium titled African Gender Perspectives on 23 October 2012. Activists, scholars and community-based workers will speak at the symposium about their work in the field of gender and gender-based violence.

Keynote speakers include Cheryl Potgieter (University of KwaZulu-Natal), Bette Dickerson (American University, Washington, D.C) and Jennifer Fish (Old Dominion University, Norfolk, Virginia). Dickerson and Fish will be speaking about their participatory action research with the group Grandmothers Against Poverty and Aids (GAPPA) who are based in Khayelitsha, Cape Town. Fish will also talk about her experience of setting up a gender centre in Rwanda.

The women’s support network Sisters for Sisters from Woodstock, Cape Town will give a presentation on their community work with women from various parts of the African continent that have experienced multiple forms of gender-based violence, and they will expand on their experiences of participating in an academic research project.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept